Sernova Corp. is a Canadian-based health sciences company focused on product development and commercialization of innovative proprietary platformmedical technologies in the cell therapy arena such as the Cell Pouch System(TM) to provide a safe and efficacious environment for therapeutic cells and Sertolin(TM), a technology which, when combined with cell therapy, may protect therapeutic cells without the need for patients to take anti-rejection drugs. Sernova's first cell therapy application is for insulin-dependent diabetes to reduce or eliminate the need for insulin injections.
website: www.sernova.com
email: info@sernova.com